Company Overview - Biotalys NV is an Agricultural Technology (AgTech) company focused on developing precision biocontrol solutions based on proteins for crop protection in both pre- and post-harvest markets [2] - The company utilizes its AGROBODY™ technology platform to create a diverse pipeline of product candidates aimed at addressing key crop pests and diseases, ensuring a favorable safety profile [2] - Founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), Biotalys is headquartered in Ghent, Belgium, and is listed on Euronext Brussels [2] Share Capital and Voting Rights - The total share capital of Biotalys is EUR 5,555,181.05, with a total of 37,568,645 ordinary shares carrying voting rights [3] - The number of rights to subscribe for securities carrying voting rights not yet issued includes 1,779,400 "ESOP Warrants" and 1,504,867 additional "ESOP Warrants" [3] - There are 28,653 share units awarded to independent directors, each obligating the subscription to one new share at an issue price of one EUR per share-unit, with cash settlement options available [3] - The company currently has no outstanding convertible bonds or non-voting shares [3]
Regulated information
Globenewswire·2025-10-20 16:00